Metabolomics in diabetic complications

Molecular BioSystems
Laura A Filla, James L Edwards

Abstract

With a global prevalence of 9%, diabetes is the direct cause of millions of deaths each year and is quickly becoming a health crisis. Major long-term complications of diabetes arise from persistent oxidative stress and dysfunction in multiple metabolic pathways. The most serious complications involve vascular damage and include cardiovascular disease as well as microvascular disorders such as nephropathy, neuropathy, and retinopathy. Current clinical analyses like glycated hemoglobin and plasma glucose measurements hold some value as prognostic indicators of the severity of complications, but investigations into the underlying pathophysiology are still lacking. Advancements in biotechnology hold the key to uncovering new pathways and establishing therapeutic targets. Metabolomics, the study of small endogenous molecules, is a powerful toolset for studying pathophysiological processes and has been used to elucidate metabolic signatures of diabetes in various biological systems. Current challenges in the field involve correlating these biomarkers to specific complications to provide a better prediction of future risk and disease progression. This review will highlight the progress that has been made in the field of metabolomics i...Continue Reading

References

Dec 1, 1975·Circulation Research·M J RovettoJ R Neely
Aug 19, 1976·The New England Journal of Medicine·R J KoenigA Cerami
Nov 1, 1991·The American Journal of Clinical Nutrition·T TodescoD J Jenkins
Apr 19, 1973·The New England Journal of Medicine·K H Gabbay
Oct 9, 1969·The New England Journal of Medicine·P FeligG F Cahill
Jan 1, 1996·Current Eye Research·A IshikawaM Tamai
Jul 23, 2003·Journal of the American Society of Nephrology : JASN·Stephen S M ChungSookja K Chung
Jul 23, 2003·Journal of the American Society of Nephrology : JASN·Josephine M ForbesMerlin C Thomas
Jul 29, 2003·Diabetes·Roya Babaei-JadidiPaul J Thornalley
Nov 25, 2003·The Annals of Pharmacotherapy·Stephen M SetterClifton J Cahoon
Dec 20, 2003·American Journal of Nephrology·W Kline BoltonUNKNOWN ACTION I Investigator Group
Jan 2, 2004·The New England Journal of Medicine·Robert N Frank
Apr 27, 2005·The Analyst·Warwick B DunnHelen E Johnson
Oct 6, 2005·Chembiochem : a European Journal of Chemical Biology·Elizabeth J WantGary Siuzdak
Nov 30, 2006·PLoS Medicine·Colin D Mathers, Dejan Loncar
Sep 28, 2007·The New England Journal of Medicine·Timothy W Meyer, Thomas H Hostetter
Jul 12, 2008·Pharmacology & Therapeutics·James L EdwardsEva L Feldman
Sep 19, 2008·American Journal of Physiology. Cell Physiology·Min ZhangPonugoti Vasantha Rao
May 8, 2009·Apoptosis : an International Journal on Programmed Cell Death·Christine M KusminskiPhilipp E Scherer
Jul 14, 2009·Diabetes·Andrea M VincentEva L Feldman
Sep 15, 2009·Journal of Diabetes and Its Complications·Kate E SchemmelJennifer J D'Souza
Oct 31, 2009·Diabetes·James R BainChristopher B Newgard
Jan 29, 2010·Diabetes Care·UNKNOWN American Diabetes Association
Apr 9, 2010·Investigative Ophthalmology & Visual Science·Ignasi BarbaRafael Simó
Oct 12, 2010·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Iwao NakabayashiMasaharu Yoshida
Oct 30, 2010·Circulation Research·Ferdinando Giacco, Michael Brownlee

❮ Previous
Next ❯

Citations

Jul 22, 2017·Journal of the American Chemical Society·Michael J KleinArumugam Manthiram
Sep 25, 2017·Current Diabetes Reports·Gerald LiewBen Crossett
Sep 29, 2017·Critical Reviews in Clinical Laboratory Sciences·Nektaria Papadopoulou-MarketouIoannis Papassotiriou
Oct 25, 2017·Nature Reviews. Nephrology·Kengo AzushimaThomas M Coffman
Jun 29, 2018·Metabolomics : Official Journal of the Metabolomic Society·Sang Youl RheeChoong Hwan Lee
Aug 6, 2017·Journal of Diabetes Investigation·Tao WuGuang Ji
Dec 12, 2020·Antioxidants·Thangal YumnamchaAhmed S Ibrahim
Apr 5, 2021·Diabetes Research and Clinical Practice·Qi ZhangBin Lu
Jun 16, 2021·Parasites & Vectors·Mingxing ZhuWei Zhao
May 27, 2020·Journal of Proteome Research·Xi ZhangHongchang Gao
Oct 12, 2021·Clinical Chemistry·John D Odom, V Reid Sutton

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

Bioinformatics in Biomedicine

Bioinformatics in biomedicine incorporates computer science, biology, chemistry, medicine, mathematics and statistics. Discover the latest research on bioinformatics in biomedicine here.

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.

Biomarkers for Diabetes

This feed focuses on the latest research on biomarkers used for monitoring disease progression in diabetes.